| |
At Academy 2003 Dallas, you will have the chance to get CE at all events: lectures and workshops, scientific papers and posters, and section symposia.
The grid of education at the meeting can be accessed here in PDF format.
Plan your meeting online! You are able to search for keywords, specific authors, topic areas to plan your time at Academy 2003 Dallas.
Special Events
Plenary Session: "The Future in Sight: Today's Research, Tomorrow's Practice™"
Hirsch Research Symposium: "Macular Degeneration: Science Impacting Sight"
ARVO/AAO Joint Symposium: "Understanding the Basis and Treatment of Dry Eye"
Opening Plenary Session:
Sponsored by Vision Service Plan
Thursday December 4, 2003: 12-2pm
Dallas, Texas
"The Future in Sight: Today's Research, Tomorrow's Practice™"
Academy 2003 Dallas will be opened by internationally renowned clinicians and clinician researchers. Their keynote presentations will highlight the advances and discoveries in our understanding of nerve cell death, nerve cell protection and nerve regeneration in central nervous system diseases. These discoveries, and recent glaucoma clinical trial research, have informed the newest treatments of glaucoma and point to new horizons in glaucoma management.
The luncheon plenary session will herald 4 days of Academy programs of continuing education, symposia, papers, posters and exhibits.
Speakers include:
Tom Lewis OD PhD
Pennsylvania College of Optometry
Philadelphia, Pennsylvania
Moderator:"The Future in Sight: Today's Research, Tomorrow's Practice™"
Leonard A. Levin, MD, PhD
Department of Ophthalmology and Visual Sciences
University of Wisconsin Medical School
Madison, Wisconsin
"Discoveries About the Death, Protection & Regeneration of
Neurons: Lessons and Prospects for Glaucoma Management"
Paul F. Palmberg MD, PhD
Department of Ophthalmology, University of Miami School of Medicine, Bascom Palmer Eye Institute Miami, Florida
"Advances in Glaucoma Treatment"
John Flanagan, OD, PhD, FAAO
School of Optometry, University of Waterloo, Canada
Department of Ophthalmology and Vision Sciences, University of Toronto Director, Toronto Glaucoma Research Unit, Toronto Western Research Institute
"From Research to the Optometric Practice: Discoveries and Opportunities"
Back to top
Sponsored by Alcon
Sunday, December 7, 2003
9:00am – 11:30am
Macular Degeneration: Science Impacting Sight
Age-related macular degeneration (ARMD) is one of the leading causes of blindness in the United States. Learn about the forms of ARMD, the current trends in research that will affect future treatment, the impact of ARMD on lifestyle, and the possible impact of low vision intervention.
Histopathology and Clinical Correlation
Deepak Edward, MD
University of Illinois
Background information on ARMD (Wet and Dry Forms)
Histopathology and how it relates with the clinical disease and vision loss
New Treatment Strategies
Abbot Clark, PhD
Alcon R&D
Discussion of pre-clinical study design for ARMD
Current trends in research for future treatments
Peter Kaiser, MD
The Cleveland Clinic
Current treatment options for wet and dry ARMD
Nutritional / vitamins
Surgical – (Invasive)
Surgical – (Laser)
Photo Dynamic Therapy
Future potential treatment options for wet and dry ARMD
Impact of Treatments on Low Vision
Paul Freeman, OD
Allegheny General Hospital
Functional impact of ARMD on lifestyle
Methods of resolving issues
Joan Stelmack, OD
Johns Hopkins
Presentation of outcome based research and information
Are we making an impact with low vision intervention?
Panel Discussion
Back to top
Understanding the Basis and Treatment of Dry Eye
Alan Tomlinson, PhD, DSc, FCOptom, FAAO
William H. Ridder, III, OD, PhD, FAAO
The goal of this symposium is to bring together leaders in the study of dry eye to present the latest developments in this exciting field. By bringing together several noted basic science and clinical researchers, our goal is to educate clinicians and vision scientists in other fields about the most recent research advances and future directions in dry eye diagnosis and treatment. The symposium will conclude with a panel discussion that will specifically address the clinical implications of these developments for optometry.
One definition states that, “Dry eye is a disorder of the tear film due to tear deficiency or excessive tear evaporation which causes damage to the interpalpebral ocular surface and is associated with symptoms of ocular discomfort.” This definition covers a multiplicity of clinical conditions. The prevalence of dry eye is estimated at 10% to 20% of the adult population with 45% of the population over 65 reporting one or more symptoms of dry eye. The past 25 years has shown significant developments in the understanding of the pathophysiology, diagnosis and management of dry eye. The role of tear biochemistry, systemic disease, and gender in its etiology and the development of new objective and subjective methods of assessment have led to greater understanding of this disease entity. The recent development of new management techniques and chemotherapy for dry eye provide a more optimistic future for patients.
1. Introduction to the Symposium: Alan Tomlinson, PhD, DSc, FCOptom, FAAO, Head of Department, Vision Sciences, Glasgow Caledonian University
2. Classification and Diagnosis of Dry Eye: Anthony J. Bron, FRCS, Nuffield Laboratory of Ophthalmology, University of Oxford, England
3. Tear Biochemistry and the Pathology of Dry Eye: David A. Sullivan, PhD, Schepens Eye Research Institute, Boston, Massachusetts
4. Objective Measurements of Tear Physiology: Alan Tomlinson, PhD, DSc, FCOptom, Glasgow Caledonian University, Scotland
5. Dry Eye is a Subjective Disease: Carolyn G. Begley, OD, MS, School of Optometry, Indiana University, Bloomington, Indiana
6. Visual Effects of Dry Eye: Larry N. Thibos, PhD, School of Optometry, Indiana University, Bloomington, Indiana
7. Treatment of the Dry Eye: The Development of New Modalities: Stephen C. Pflugfelder, MD, Cullen Eye Institute, Houston, Texas
Panel Discussion: Alan Tomlinson, PhD, DSc, FCOptom and William H. Ridder, III, OD, PhD
The panel will consist of prominent optometrists in the field of dry eye who will lead the discussion session.
The Academy’s Section on Cornea & Contact Lenses and Vision Sciences Section invite you to attend the post-symposium reception, generously sponsored by Allergan.
Back to top
|
|
